AMLX icon

Amylyx Pharmaceuticals

130 hedge funds and large institutions have $524M invested in Amylyx Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 37 increasing their positions, 37 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
-4
Holders Change %
-2.99%
% of All Funds
1.74%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.08%
New
32
Increased
37
Reduced
37
Closed
36
Calls
$1.48M
Puts
$103K
Net Calls
+$1.38M
Net Calls Change
+$1.46M
Name Holding Trade Value Shares
Change
Shares
Change %
PP
151
Paloma Partners
Connecticut
-$78.7K -22,242 Closed
Capstone Investment Advisors
152
Capstone Investment Advisors
New York
-$57.2K -16,150 Closed
SOW
153
State of Wyoming
Wyoming
-$56.4K -15,920 Closed
CFM
154
Catalyst Funds Management
Australia
-$52.8K -14,905 Closed
HSBC Holdings
155
HSBC Holdings
United Kingdom
-$51.4K -14,419 Closed
EGM
156
Engineers Gate Manager
New York
-$47.4K -13,382 Closed
TSS
157
Two Sigma Securities
New York
-$47.1K -13,301 Closed
RS
158
R Squared
Hong Kong
-$45.1K -12,736 Closed
BHCM
159
Brevan Howard Capital Management
Jersey
-$40.1K -11,330 Closed
CM
160
Capula Management
Cayman Islands
-$38.9K -10,980 Closed
EC
161
EntryPoint Capital
New York
-$37.5K -10,587 Closed
Hudson Bay Capital Management
162
Hudson Bay Capital Management
Connecticut
-$36.6K -10,340 Closed
PD
163
Point72 (DIFC)
United Arab Emirates
-$17.9K -5,047 Closed
Simplex Trading
164
Simplex Trading
Illinois
-$14K -4,162 Closed
AAM
165
Advisors Asset Management
Colorado
-$9.11K -2,573 Closed
CCM
166
Coldstream Capital Management
Washington
-$843 -238 Closed